重组Anti-AKT1 + AKT2 + AKT3抗体[EPR17737]
Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- 了解详情
Be the first to review this product! Submit a review
|
(13 Publications)
Rabbit Recombinant Monoclonal AKT1 antibody. Suitable for WB, ICC/IF and reacts with Recombinant fragment, Mouse, Rat, Human samples. Cited in 13 publications.
查看别名
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized MCF7 (Human breast adenocarcinoma cell line) cells labeling AKT1 + AKT2 + AKT3 with ab200195 at 1/1000 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green).
Cytoplasm staining on MCF7 cell line is observed.
The nuclear counter stain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab200195 at 1/1000 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/10000 dilution
Lane 1:
PC-3 (Human prostate cancer cell line) whole cell lysate at 10 µg
Lane 2:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 10 µg
Lane 3:
293 (Human embryonic kidney) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution
All lanes:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/10000 dilution
All lanes:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution
Lane 1:
Human fetal brain tissue lysate at 10 µg
Lane 2:
Human fetal heart tissue lysate at 10 µg
Lane 3:
Human fetal kidney tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution
Lane 1:
Mouse brain lysate at 10 µg
Lane 2:
Mouse spleen lysate at 10 µg
Lane 3:
Rat brain lysate at 10 µg
Lane 4:
Rat heart lysate at 10 µg
Lane 5:
C6 (Rat glial tumor cells) whole cell lysate at 10 µg
Lane 6:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
AKT3 recombinant protein fragment contains aa351-479 with His-Tag®. AKT2 recombinant protein fragment contains aa282-481 with His-Tag® and AKT1 recombinant protein fragment contains aa281-480 with His-Tag®.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (ab200195) at 1/2000 dilution
Lane 1:
AKT3 recombinant protein fragment (His-Tag®): aa351-479 at 0.01 µg
Lane 2:
AKT2 recombinant protein fragment (His-Tag®): aa282-481 at 0.01 µg
Lane 3:
AKT1 recombinant protein fragment (His-Tag®): aa281-480 at 0.01 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 56 kDa
false
Exposure time: 3s
- WB
CiteAb
Western blot - Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] (AB200195)
AKT1 + AKT2 + AKT3 western blot using anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] ab200195. Publication image and figure legend from Wang, Z., Liu, Y., et al., 2020, Oxid Med Cell Longev, PubMed 31998436.
ab200195 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab200195 please see the product overview.
Nrf2 signaling regulated by PI3K/Akt activation is involved in AM-mediated liver protection in mice with chronic alcohol injury. (a) AM and Sil increased the expression levels of P-PI3K, P-Akt, P-Stat3, Nrf2, SOD-1/2, and HO-1/2 in livers. (b) AM and Sil increased the expression levels of Nrf2 in the cytoplasm and nucleus of liver tissues. The data of quantified protein expressions were normalized by related total protein expressions, GAPDH, β-actin, and/or lamin B. The data were analyzed using one-way ANOVA and expressed as means ± S.E.M. (n = 4). ##p < 0.01 and ###p < 0.001 vs. the control group; *p < 0.05, **p < 0.01, and ***p < 0.001 vs. the alcohol-only treated model group. AM : Aronia melanocarpa; Sil : silybin.
false
不同偶联物与剂型 (1)
-
Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737] - BSA and Azide free
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT proteins regulate cell cycle growing cell survival proliferation and metabolism. They participate as core components of the PI3K/AKT/mTOR signaling pathway forming complexes with other proteins to transmit signals. They bind to phosphoinositide lipids on the cell membrane facilitating their activation and downstream signaling. Through these activities the AKT transporter proteins maintain cellular homeostasis and play a part in stress response.
Pathways
AKT proteins engage in important signaling networks including the PI3K/AKT pathway and mTOR pathway. They work closely with PI3K and mTOR proteins coordinating cellular growth and energy metabolism. In particular the AKT pathway responds to growth factors and insulin influencing glucose uptake and glycolysis regulation through interaction with proteins such as glycogen synthase kinase 3 (GSK3).
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
其他靶点
文献 (13)
Recent publications for all applications. Explore the full list and refine your search
Nutrients 17: PubMed40077694
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:898906 PubMed35662701
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biological & pharmaceutical bulletin 45:143-149 PubMed34707025
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:11150-11169 PubMed33819182
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 11:656184 PubMed33816313
2021
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 13:12225-12241 PubMed33273828
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32784451
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in microbiology 11:1113 PubMed32719658
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological macromolecules 156:204-216 PubMed32156537
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2020:4054520 PubMed31998436
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com